Protherics PLC
6 monthly Block Listing Return in respect of
6% unsecured convertible loan notes
London, UK; Brentwood, TN, US: 9 February 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that the following 6 monthly block listing return in
respect of the Company's 6% unsecured convertible loan notes has been lodged
with the FSA today, in accordance with Listing Rule 3.5.6.
Name of applicant: Protherics PLC
Name of scheme: Block Listing in respect of 6% Unsecured Convertible Loan
Notes
Period of return: From: 8 August 2006 To: 8 February 2007
Balance under scheme from previous return: 9,617,236 Ordinary Shares (Loan Notes to the value of
£2,404,309.00)
The amount by which the block scheme has been increased, 68,200 Ordinary Shares (Loan Notes to the value of
if the scheme has been increased since the date of the £17,050.00)
last return:
Number of securities issued/allotted under scheme during 768,040 Ordinary Shares (Loan Notes to the value of
period: £192,010.00)
Balance under scheme not yet issued/allotted at end of 8,917,396 Ordinary Shares (Loan Notes to the value of
period £2,229,349.00)
Number and class of securities originally listed and the 17,092,476 Ordinary Shares (Loan Notes to the value of
date of admission £4,273,119.00) admitted on 8 February 2005
Total number of securities in issue at the end of the 339,086,994 Ordinary Shares
period
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518000
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Blocklisting Interim Review
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- February 9, 2007 --